Shares of Tate & Lyle PLC (LON:TATE) have received an average recommendation of “Hold” from the fourteen brokerages that are covering the company. Nine equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is GBX 726.25 ($9.48).

A number of research firms have recently commented on TATE. Numis Securities Ltd restated a “hold” rating and issued a GBX 670 ($8.75) price objective on shares of Tate & Lyle PLC in a report on Friday, July 22nd. Liberum Capital restated a “buy” rating and issued a GBX 790 ($10.31) price objective on shares of Tate & Lyle PLC in a report on Tuesday, July 5th. BNP Paribas restated a “neutral” rating and issued a GBX 700 ($9.14) price objective on shares of Tate & Lyle PLC in a report on Thursday, September 8th. Davy Research restated a “neutral” rating on shares of Tate & Lyle PLC in a report on Wednesday, June 22nd. Finally, Berenberg Bank set a GBX 715 ($9.33) price objective on Tate & Lyle PLC and gave the stock a “neutral” rating in a report on Friday, July 22nd.

In related news, insider Frederiksen,Lars acquired 15,000 shares of Tate & Lyle PLC stock in a transaction that occurred on Monday, July 25th. The stock was acquired at an average price of GBX 699 ($9.12) per share, for a total transaction of £104,850 ($136,862.03). Also, insider Hampton,Nick sold 45,600 shares of the business’s stock in a transaction that occurred on Friday, August 19th. The shares were sold at an average price of GBX 739 ($9.65), for a total value of £336,984 ($439,869.47).

Tate & Lyle PLC (LON:TATE) opened at 773.00 on Friday. The firm’s market capitalization is GBX 3.59 billion. The company has a 50-day moving average price of GBX 733.15 and a 200-day moving average price of GBX 660.37. Tate & Lyle PLC has a one year low of GBX 529.00 and a one year high of GBX 781.00.

About Tate & Lyle PLC

Tate & Lyle PLC provides ingredients and solutions to the food, beverage and other industries. The Company operates through two business segments: Speciality Food Ingredients, which offers products, such as sweeteners, texturants, health and wellness, and food systems, and Bulk Ingredients segment, which offers products, such as liquid sweeteners, industrial starches, citric acid, bio-fuels and animal feed.

Receive News & Stock Ratings for Tate & Lyle PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle PLC and related stocks with our FREE daily email newsletter.